The human KB multidrug-resistant cell line KB-C1 is hypersensitive to inhibitors of glycosylation

被引:40
作者
Bentley, J [1 ]
Quinn, DM [1 ]
Pitman, RS [1 ]
Warr, JR [1 ]
Kellett, GL [1 ]
机构
[1] UNIV YORK,DEPT BIOL,YORK YO1 5YW,N YORKSHIRE,ENGLAND
关键词
P-glycoprotein; glucose transporter; tunicamycin; 2-deoxy-D-glucose;
D O I
10.1016/S0304-3835(97)04739-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have previously shown that the hypersensitivity of KB MDR cells to 2-deoxy-D-glucose is associated with diminished plasma membrane GLUT-1 levels compared with parental, non-MDR cells. Here we report that MDR cells are hypersensitive to the N-linked glycosylation inhibitor tunicamycin, which induces partial inhibition of GLUT-1 glycosylation and diminishes GLUT-1-mediated transport. The effect of tunicamycin, which also enhances the hypersensitivity of MDR cells to 2-deoxy-D-glucose, could not be attributed to alterations in P-glycoprotein activity. The use of agents that act synergistically to diminish the level and activity of GLUT-1 in MDR cells may be of clinical potential. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 16 条
  • [1] THE ROLE OF N-GLYCOSYLATION IN THE TARGETING AND STABILITY OF GLUT1 GLUCOSE-TRANSPORTER
    ASANO, T
    TAKATA, K
    KATAGIRI, H
    ISHIHARA, H
    INUKAI, K
    ANAI, M
    HIRANO, H
    YAZAKI, Y
    OKA, Y
    [J]. FEBS LETTERS, 1993, 324 (03) : 258 - 261
  • [2] Bentley J, 1996, ONCOL RES, V8, P77
  • [3] HETEROGENEITY OF THE GLUCOSE TRANSPORTER IN MALIGNANT AND SUPPRESSED HYBRID-CELLS
    BRAMWELL, ME
    DAVIES, A
    BALDWIN, SA
    [J]. EXPERIMENTAL CELL RESEARCH, 1990, 188 (01) : 97 - 104
  • [5] GOTTESMAN MM, 1993, CANCER RES, V53, P747
  • [6] MODIFICATION OF TUMOR GLUCOSE-METABOLISM FOR THERAPEUTIC BENEFIT
    HAMILTON, E
    FENNELL, M
    STAFFORD, DM
    [J]. ACTA ONCOLOGICA, 1995, 34 (03) : 429 - 433
  • [7] HARRISON SA, 1990, J BIOL CHEM, V265, P20106
  • [8] KITAGAWA T, 1995, J CELL SCI, V108, P3735
  • [9] INHIBITION OF N-LINKED GLYCOSYLATION OF P-GLYCOPROTEIN BY TUNICAMYCIN RESULTS IN A REDUCED MULTIDRUG-RESISTANCE PHENOTYPE
    KRAMER, R
    WEBER, TK
    ARCECI, R
    RAMCHURREN, N
    KASTRINAKIS, WV
    STEELE, G
    SUMMERHAYES, IC
    [J]. BRITISH JOURNAL OF CANCER, 1995, 71 (04) : 670 - 675
  • [10] LYON RC, 1988, CANCER RES, V48, P870